4-phenylbutyric acid has been researched along with olanzapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, J; Gao, G; He, M; Hu, J; Huang, XF; Li, J; Li, W; Sun, T; Zhou, T | 1 |
1 review(s) available for 4-phenylbutyric acid and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for 4-phenylbutyric acid and olanzapine
| Article | Year |
|---|---|
Olanzapine-induced endoplasmic reticulum stress and inflammation in the hypothalamus were inhibited by an ER stress inhibitor 4-phenylbutyrate.
Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; eIF-2 Kinase; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Humans; Hypothalamus; I-kappa B Kinase; Inflammation; NF-kappa B; Olanzapine; Phenylbutyrates; Rats; Rats, Sprague-Dawley; Signal Transduction | 2019 |